Manganese Superoxide Dismutase Polymorphism, Prediagnostic Antioxidant Status, and Risk of Clinical Significant Prostate Cancer
Open Access
- 15 March 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 65 (6) , 2498-2504
- https://doi.org/10.1158/0008-5472.can-04-3535
Abstract
Oxidative stress may enhance prostatic carcinogenesis. A polymorphism [valine (V) → alanine (A)] of manganese superoxide dismutase (MnSOD), the primary antioxidant enzyme in mitochondria, has been recently associated with prostate cancer. We examined the relationship between prostate cancer and the MnSOD polymorphism and its interactions with baseline plasma antioxidant levels (selenium, lycopene, and α-tocopherol) and β-carotene treatment among 567 cases and 764 controls nested in the prospective Physicians' Health Study. We found little overall association between MnSOD polymorphism and prostate cancer risk; however, this polymorphism significantly modified risk of prostate cancer associated with prediagnostic plasma antioxidants (Pinteraction ≥ 0.05). Among men with the AA genotype, high selenium level (4th versus 1st quartile) was associated with a relative risk (RR) of 0.3 [95% confidence interval (CI), 0.2-0.7] for total prostate cancer; for clinically aggressive prostate cancer, the RR was 0.2 (95% CI, 0.1-0.5). In contrast, among men with the VV/VA genotype, the RRs were 0.6 (0.4-1.0) and 0.7 (0.4-1.2) for total and clinically aggressive prostate cancer. These patterns were similar for lycopene and α-tocopherol and were particularly strong when these antioxidants and selenium were combined; men with the AA genotype had a 10-fold gradient in risk for aggressive prostate cancer across quartiles of antioxidant status. Men with AA genotype who were randomly assigned to β-carotene treatment (versus placebo) had a RR of 0.6 (95% CI, 0.2-0.9; Pinteraction = 0.03) for fatal prostate cancer, but no significant association was observed in men with the VV/VA genotype. Both endogenous and exogenous antioxidants play an important and interdependent role in preventing clinically significant prostate cancer.Keywords
This publication has 28 references indexed in Scilit:
- Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studiesBJU International, 2004
- Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer riskCarcinogenesis: Integrative Cancer Research, 2004
- Superoxide dismutases in malignant cells and human tumorsFree Radical Biology & Medicine, 2004
- MnSOD polymorphism and breast cancer in a population-based case–control studyCancer Letters, 2003
- A Prospective Study of Tomato Products, Lycopene, and Prostate Cancer RiskJNCI Journal of the National Cancer Institute, 2002
- Decreased incidence of prostate cancer with selenium supplementation: results of a double‐blind cancer prevention trialBritish Journal of Urology, 1998
- Structural Dimorphism in the Mitochondrial Targeting Sequence in the Human Manganese Superoxide Dismutase Gene: A Predictive Evidence for Conformational Change to Influence Mitochondrial Transport and a Study of Allelic Association in Parkinson's Disease: Volume226,Number 2 (1996), pages 561–565:Biochemical and Biophysical Research Communications, 1996
- Lack of Effect of Long-Term Supplementation with Beta Carotene on the Incidence of Malignant Neoplasms and Cardiovascular DiseaseNew England Journal of Medicine, 1996
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- Diagnosis, staging, and surgical treatment of prostatic carcinomaArchives of internal medicine (1960), 1987